ROCKVILLE, Md., Aug. 31, 2011 /PRNewswire/ — Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ:
VNDA), a biopharmaceutical company focused on the development
and commercialization of products for central nervous system
disorders, today announced that Mihael H. Polymeropoulos, M.D.,
Vanda President and CEO will deliver a corporate presentation at
the Stifel Nicolaus Global Healthcare Conference in Boston, MA on
Thursday, September 8, 2011 at 4:25 pm Eastern Time.
Dr. Polymeropoulos’ presentation at the Stifel Nicolaus Global
Healthcare Conference will be available live on Vanda’s corporate
website, where it also will be archived for 30 days. To
access the presentation, log on to http://www.vandapharma.com
and click on the Presentations option in the Investor Relations
section. Please connect to the website several minutes prior to the
start of the live presentation.
On Friday, September 9, 2011, members of the Vanda executive
management team will participate in the Jefferies Fall 2011
Mid-Atlantic Corporate Access Day held in Baltimore, MD.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company
focused on the development and commercialization of products for
central nervous system disorders. For more on Vanda Pharmaceuticals
Inc., please visit http://www.vandapharma.com.
Company Contact:
Cristina Murphy
Communications Manager
Vanda Pharmaceuticals Inc.
(240) 599-4500
‘/>”/>
SOURCE
